HVR Cardio
Finland - EspooMedical Devices
Focus: HVR Cardio is a public medical device company headquartered in Finland specializing in transcatheter mitral valve repair products for the cardiovascular market. The company operates in a focused, high-value segment of interventional cardiology.
Profile data last refreshed 22h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About HVR Cardio
AI assessmentNot HiringNo open roles listed right now. Follow HVR Cardio to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Transcatheter Mitral Valve Repair
Mitral Valve Regurgitation (Degenerative or Functional)Clinical Trials (1)
NCT07188233Mitral Annular Repair With the CathHELIX™ Transcatheter System in Subjects With FMR
N/AHelp build intelligence for HVR Cardio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.